Prepared By, Starlin

Cpk in the
Pharmaceutical
Industry
 Prepared By, Starlin

Detailed Explanation of Cpk

 The Process Capability Index (Cpk) is a measure that
evaluates how well a process is performing in terms of
meeting the specified product quality standards.
 It compares the allowable limits (based on product
specifications) to the actual variability (spread of the
process) and gives a value that indicates how well the
process can stay within these limits.
 Prepared By, Starlin

Cpk Formula and Components

The formula for calculating Cpk is:
𝑈𝑆𝐿 − 𝜇​ 𝜇 − 𝐿𝑆𝐿
𝐶𝑝𝑘 = min( , )
3𝜎 3𝜎
Where:
USL (Upper Specification Limit): The maximum
value allowed for a product characteristic (e.g.,
tablet weight, concentration of active ingredient).
 Prepared By, Starlin

Cpk Formula and Components (contd)

LSL (Lower Specification Limit): The minimum
value allowed for the product characteristic.
μ (Mean): The average of all data points from
the process.
σ (Standard Deviation): A measure of how
spread out the data is, indicating the variability
in the process.
 Prepared By, Starlin

Cpk Formula and Components (contd)

The Cpk is calculated by determining the
number of standard deviations the process
mean is away from the nearest specification
limit.
The process with a higher Cpk is considered
more capable, meaning it’s more likely to
produce products that meet the specifications.
 Prepared By, Starlin

Steps to Interpret Cpk

 ProcessMean (μ): This is the center of the distribution,
representing the typical or average value of the process.
 Specification
Limits (USL and LSL): These are the acceptable
range for product attributes (such as weight, potency, or
concentration).
 StandardDeviation (σ): This measures how much the process
output varies from the mean. A smaller standard deviation
means the process is more consistent.
 Prepared By, Starlin

Steps to Interpret Cpk

IfCpk is high, it suggests that the process
produces products with minimal variation
and is well-centered between the
specification limits.
IfCpk is low, it indicates more variation
and possible defects.
 Prepared By, Starlin

Step-by-Step Calculation of Cpk:

 Prepared By, Starlin

Example Scenario
Let'swalk through a pharmaceutical
example: a company is producing tablets,
and one of the critical quality attributes is
the weight of the tablets.
 Prepared By, Starlin

Example Scenario (Contd)

Tablet Weights (mg): 496, 497, 495, 502,
501, 498, 500, 501, 499, 497
Target Weight (μ): 500 mg
Lower Specification Limit (LSL): 490 mg
Upper Specification Limit (USL): 510 mg
 Prepared By, Starlin

Step 1: Calculate the Mean (μ)

 The mean is the average of the tablet weights. The
formula for the mean is
∑𝑋
𝜇=
𝑛
 Where: X = individual tablet weights
 n = number of samples (in this case, 10 tablets)
 The tablet weights are: 496, 497, 495, 502, 501, 498, 500,
501, 499, 497.
 Prepared By, Starlin

Step 1: Calculate the Mean (μ)

496+497+495+502+501+498+500+501+499+497
𝜇=
10
4995​
𝜇= = 499.5 𝑚𝑔
10
 Prepared By, Starlin

Calculate the Standard Deviation (σ)

The formula for standard deviation is:
∑(𝑋𝑖 −𝜇)2
𝜎=
𝑛
Where: 𝑋𝑖 = each individual tablet weight
μ = mean
n = number of samples
 Prepared By, Starlin

Calculate the Standard Deviation (σ)

 Prepared By, Starlin

Calculate the Standard Deviation (σ)

∑(𝑋𝑖 − 𝜇)2 = 12.25 + 6.25 + 20.25 +

6.25 + 2.25 + 2.25 + 0.25 + 2.25 + 0.25 +
6.25 = 58.50
 Prepared By, Starlin

Calculate the Standard Deviation (σ)

Now, divide by the number of samples (n =

10) and take the square root:

58.50
𝜎= = 5.85 ≈ 2.42 𝑚𝑔
10
 Prepared By, Starlin

Step 3: Calculate Cpk

The formula for calculating Cpk is:
𝑈𝑆𝐿 − 𝜇​ 𝜇 − 𝐿𝑆𝐿
𝐶𝑝𝑘 = min( , )
3𝜎 3𝜎
USL = 510 mg
LSL = 490 mg
μ = 499.5 mg
σ = 2.42 mg
 Prepared By, Starlin

Step 3: Calculate Cpk

Cpk for USL:
𝑈𝑆𝐿 − 𝜇 510 − 499.5 10.5
= = ≈ 1.45
3σ 3 × 2.42 7.26
 Prepared By, Starlin

Step 3: Calculate Cpk

Cpk for LSL:
𝜇 − 𝐿𝑆𝐿 499.5 − 490 9.5
= = ≈ 1.31
3σ 3 × 2.42 7.26
 Prepared By, Starlin

Step 3: Calculate Cpk

Finally, take the minimum of the two
values:
𝐶𝑝𝑘 = min(1.45,1.31) = 1.31
 Prepared By, Starlin

Step 4: Interpretation
Cpk = 1.31 means that the process is capable of
producing tablets within the specification
limits with a good level of consistency, but
there is still room for improvement.
Typically, a Cpk greater than 1.33 is
considered acceptable for a process to meet
specifications consistently.
 Prepared By, Starlin

Impact of Cpk on
Pharmaceutical
Processes
 Prepared By, Starlin

Consistency in Active Ingredient Dosage

Consistency is key in pharmaceutical
manufacturing, as variations in weight
could impact the dosage of the active
pharmaceutical ingredient (API),
potentially leading to under-dosing or
overdosing.
 Prepared By, Starlin

Compliance with Regulatory Requirements

Regulatory bodies like the FDA or EMA set strict

requirements for pharmaceutical manufacturing
processes. A high Cpk demonstrates the
company’s ability to maintain consistent quality
and meet these regulatory requirements. A Cpk of
1.33 or higher is often considered the minimum
acceptable standard in pharmaceutical production.
 Prepared By, Starlin

Reduction in Scrap and Rework

With a high Cpk, fewer products are
outside the specified limits, which means
less waste and fewer products that need to
be reprocessed or discarded. This leads to
cost savings and improved efficiency.
 Prepared By, Starlin

Product Stability and Safety

Especially for sterile injectables, a high
Cpk ensures that parameters such as pH,
concentration, and sterility are consistently
within acceptable limits, ensuring the
safety and efficacy of the product.
 Prepared By, Starlin

Consequences of a Low Cpk

Increased Risk of Non-Compliance:
Regulatory bodies will likely flag a process
with a low Cpk, which may result in
increased scrutiny, delays in product
release, and possible regulatory actions.
 Prepared By, Starlin

Consequences of a Low Cpk

Quality Control Issues: More out-of-specification
products will be produced, leading to higher
rejection rates and potentially impacting patient
safety due to incorrect dosage.
Higher Production Costs: Increasedwaste, rework,
and process downtime contribute to higher costs.
 Prepared By, Starlin

Prepared by,

Starlin

Thank You
Ph. No: +91 8220217354

Email: linstar72@gmail.com